PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Anthocyanins from dark sweet cherries exhibited synergistic inhibition of cell viability when combined with Doxorubicin in 4T1 triple-negative breast cancer cells [PMID:40136467]
Extracts from stems, leaves, and flowers of Portuguese sweet cherries inhibited nitrite production in LPS-stimulated mouse macrophages in a dose-dependent manner [PMID:36364838]
Safety & adverse effects
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 35736682 (2022) — Fruit Development in Sweet Cherry. · Plants (Basel, Switzerland)
- 2.PMID: 35870155 (2023) — Methods for quality evaluation of sweet cherry. · Journal of the science of food and agriculture
- 3.PMID: 40136467 (2025) — Dark Sweet Cherry (Prunus avium L.) Juice Phenolics Rich in Anthocyanins Exhibit Potential to Inhibit Drug Resistance Mechanisms in 4T1 Breast Cancer Cells via the Drug Metabolism Pathway. · Current issues in molecular biology
- 4.PMID: 39519493 (2024) — From Orchard to Wellness: Unveiling the Health Effects of Sweet Cherry Nutrients. · Nutrients
- 5.PMID: 42197286 (2026) — Tissue-Specific Anthocyanin and Polyphenol Content in Sweet Cherry (Prunus avium L.): Effects of Freezing and Association with MYB-Based Genetic Variability.